Daniel A. Alicata to Central Nervous System Stimulants
This is a "connection" page, showing publications Daniel A. Alicata has written about Central Nervous System Stimulants.
Connection Strength
0.326
-
Ling W, Chang L, Hillhouse M, Ang A, Striebel J, Jenkins J, Hernandez J, Olaer M, Mooney L, Reed S, Fukaya E, Kogachi S, Alicata D, Holmes N, Esagoff A. Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder. Addiction. 2014 Sep; 109(9):1489-500.
Score: 0.108
-
King G, Alicata D, Cloak C, Chang L. Psychiatric symptoms and HPA axis function in adolescent methamphetamine users. J Neuroimmune Pharmacol. 2010 Dec; 5(4):582-91.
Score: 0.080
-
Nakama H, Chang L, Cloak C, Jiang C, Alicata D, Haning W. Association between psychiatric symptoms and craving in methamphetamine users. Am J Addict. 2008 Sep-Oct; 17(5):441-6.
Score: 0.072
-
Chang L, Alicata D, Ernst T, Volkow N. Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction. 2007 Apr; 102 Suppl 1:16-32.
Score: 0.065